Acetyl-L-Carnitine: Nerve, Brain and Mood Research
What trials and reviews say about acetyl-L-carnitine (ALCAR) for nerve pain, memory, dementia and low mood, including a cancer-treatment warning, in plain language.
Content last updated . This page has not been medically reviewed.
Urgent first: cancer treatment and nerve symptoms
If you are having chemotherapy, do not start acetyl-L-carnitine (ALC, also sold as ALCAR) without asking your cancer care team. In a randomized trial of women having taxane chemotherapy for breast cancer, 24 weeks of ALC led to statistically significantly worse nerve damage (chemotherapy-induced neuropathy) over two years than placebo. [1] The American Society of Clinical Oncology (ASCO, 2020) says the use of ALC to prevent this nerve damage in patients with cancer should be discouraged. [2]For low mood that lasts, or thoughts of harming yourself, contact a clinician. In the US you can call or text 988 (Suicide & Crisis Lifeline), or 911 in an emergency.
What it is
Acetyl-L-carnitine is a form of carnitine, a body compound made from the amino acids lysine and methionine. [3] It is not one of the amino acids that build proteins. Basic background is on Carnitine and Acetyl-L-Carnitine, and the L-carnitine claims are on the L-carnitine page. This page covers nerve, brain and mood research only.What the research found
| Question | What the source found | Strength |
|---|---|---|
| Chemotherapy nerve damage (prevention) | Worse nerve symptoms with ALC than placebo in 409 evaluable women in one trial. [1] ASCO discourages ALC for prevention. [2] | Evidence of harm |
| Diabetic nerve pain | A Cochrane review (2019) said it was very uncertain whether ALC reduces pain after 6 to 12 months, because evidence was sparse and of low certainty. [4] Two of the four studies were funded by the maker of ALC. [4] | Very low certainty |
| Dementia (Alzheimer's) | A Cochrane review (2003) found no evidence of benefit in cognition, severity of dementia or functional ability, and no evidence to recommend routine use. [5] | No benefit shown; older review |
| Memory in healthy people | Cochrane (2017) found only two small trials of L-carnitine and could not draw conclusions about cognitive enhancement in healthy adults. [6] | Proper evidence not found |
| Depression | A 2018 meta-analysis of 12 trials found ALC lowered depressive symptoms compared with placebo or no treatment, though results varied widely between trials, and it called for larger trials. [7] A 2026 meta-analysis reported similar findings and also called for larger long-term studies. [8] | Promising but limited |
"Proper evidence not found" means we searched PubMed and Cochrane for ALC in healthy-adult memory and in modern dementia trials and found no recent review that changes the picture. It does not mean ALC is useless or harmful.
Reading the mood results with care
The mood reviews pooled trials of different sizes and designs, and one reported high variation between trials. [7] In three trials that compared ALC with antidepressant medicines, the 2018 review found similar effects and fewer side effects with ALC. [7][8] That is a research finding, not a reason to stop or swap a prescribed antidepressant. Never stop a prescribed medicine on your own; talk to your prescriber. See stress, anxiety, burnout and depression.Memory worries
Ongoing forgetfulness, confusion or personality change should be assessed, not treated with a supplement. See memory changes: when to get help. For how nootropic claims are judged, see Nootropics.Frequently asked questions
Is acetyl-L-carnitine safe with chemotherapy?
Not as a nerve protector. A randomized trial found worse neuropathy with ALC after taxane chemotherapy, and ASCO discourages its use for prevention. [1][2] Ask your cancer team.
Does ALCAR improve memory?
In people with Alzheimer's disease a Cochrane review found no evidence of benefit, and in healthy adults the evidence was too limited to conclude. [5][6]
Does ALCAR help depression?
Two meta-analyses report lower depressive symptoms than placebo, but both ask for larger trials. [7][8] Depression needs professional assessment.
Does it help diabetic nerve pain?
The Cochrane review said the effect on pain was very uncertain because evidence was of low certainty. [4]
Is ALCAR the same as L-carnitine?
ALC is a related form, and findings for one do not automatically apply to the other. The Cochrane cognition review looked at both. [6]
More details: evidence, limits and cautions
The details behind this page: cautions, limits of the evidence and where sources disagree. Open any note to read it.
Side effects and safety
Ask a clinician or pharmacist first if you:
- are having or planning chemotherapy (see above);
- take prescribed medicines, including antidepressants or thyroid medicine (interaction data for ALC specifically were not found in the sources we read; the related L-carnitine page notes a thyroid question);
- are pregnant, breastfeeding, or giving a supplement to a child;
- have kidney or liver disease, or a seizure disorder;
- are planning surgery (supplements before surgery).
No pregnancy, child, kidney or liver safety data for ALC were in the sources we read.
References
- Hershman et al., Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L-Carnitine (SWOG S0715). J Natl Cancer Inst 2018 (abstract) Read 2026-10-23.
- Loprinzi et al., Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update. J Clin Oncol 2020 (abstract) Read 2026-10-23.
- Pekala et al., L-carnitine: metabolic functions and meaning in humans life. Curr Drug Metab 2011 (abstract) Read 2026-10-23.
- Rolim et al., Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy. Cochrane Database Syst Rev 2019 (abstract) Read 2026-10-23.
- Hudson and Tabet, Acetyl-L-carnitine for dementia. Cochrane Database Syst Rev 2003 (abstract) Read 2026-10-23.
- Chen et al., L-carnitine for cognitive enhancement in people without cognitive impairment. Cochrane Database Syst Rev 2017 (abstract) Read 2026-10-23.
- Veronese et al., Acetyl-L-Carnitine Supplementation and the Treatment of Depressive Symptoms: systematic review and meta-analysis. Psychosom Med 2018 (abstract) Read 2026-10-23.
- Kumar et al., Current Evidence of Acetyl-L-Carnitine Use in Mood Disorders: systematic review and meta-analysis. Neuropsychiatr Dis Treat 2026 (abstract) Read 2026-10-23.